Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent

Peptides

Volumn 38, Issue 2, 2012, Pages 457-462

  Wang, Ju Bo ^a   Wang, Mao De ^a   Li, En Xiao ^a   Dong, Dan Feng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Sheet; peptides; Anginex; Angiogenesis; Endothelial cell; Tumor growth

Indexed keywords

ANGINEX; ANGIOSTATIN; CARBOPLATIN; ENDOSTATIN; FIBRONECTIN; GALECTIN 1; INTERLEUKIN 8; THROMBOCYTE FACTOR 4;

AMINO ACID SEQUENCE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL ADHESION; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; DOWN REGULATION; ENDOTHELIUM CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD VESSELS; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84869101647     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.09.007     Document Type: Review

References (53)

1. M.E. Akerman, J. Pilch, D. Peters, and E. Ruoslahti Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature Proc Natl Acad Sci USA 102 2005 2040 2045
2. M. Amano, M. Suzuki, S. Andoh, H. Monzen, K. Terai, and B. Williams Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay Int J Clin Oncol 12 2007 42 47
3. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat Rev Cancer 3 2003 401 410
4. J. Blazyk, R. Wiegand, J. Klein, J. Hammer, R.M. Epand, and R.F. Epand A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids J Biol Chem 276 2001 27899 27906
5. R.J. Brandwijk, R.P. Dings, E. van der Linden, K.H. Mayo, V.L. Thijssen, and A.W. Griffioen Anti-angiogenesis and anti-tumor activity of recombinant anginex Biochem Biophys Res Commun 349 2006 1073 1078
6. R.J. Brandwijk, W.J. Mulder, K. Nicolay, K.H. Mayo, V.L. Thijssen, and A.W. Griffioen Anginex-conjugated liposomes for targeting of angiogenic endothelial cells Bioconjugate Chem 18 2007 785 790
7. S. Daopin, K.A. Piez, Y. Ogawa, and D.R. Davies Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily Science 257 1992 369 373
8. R.P. Dings, M.M. Arroyo, N.A. Lockwood, L.I. van Eijk, J.R. Haseman, and A.W. Griffioen β-Sheet is the bioactive conformation of the anti-angiogenic anginex peptide Biochem J 373 2003 281 288
9. R.P. Dings, M. Loren, H. Heun, E. McNiel, A.W. Griffioen, and K.H. Mayo Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome viavessel normalization Clin Cancer Res 13 2007 3395 3402
10. R.P. Dings, D.W. van der Schaft, B. Hargittai, J. Haseman, A.W. Griffioen, and K.H. Mayo Anti-tumor activity of the novel angiogenesis inhibitor anginex Cancer Lett 194 2003 55 66
11. R.P. Dings, E.S. Van Laar, M. Loren, J. Webber, Y. Zhang, and S.J. Waters Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6- hydroxylpropylacylfulvene Bioconjugate Chem 21 2010 20 27
12. R.P. Dings, B.W. Williams, C.W. Song, A.W. Griffioen, K.H. Mayo, and R.J. Griffin Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells Int J Cancer 115 2005 312 319
13. R.P. Dings, Y. Yokoyama, S. Ramakrishnan, A.W. Griffioen, and K.H. Mayo The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin1 Cancer Res 63 2003 382 385
14. D.F. Dong, E.X. Li, J.B. Wang, Y.Y. Wu, F. Shi, and J.J. Guo Anti-angiogenesis and anti-tumor activity of AdNT4-anginex: a recombinant adenovirus secreting and expressing anginex Cancer Lett 28 2009 218 224
15. M.J. Eck, M. Ultsch, E. Rinderknecht, A.M. de Vos, and S.R. Sprang The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9 A/resolution J Biol Chem 267 1992 2119 2122
16. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
17. J. Folkman, and M. Klagsbrun Angiogenic factors Science 235 1987 442 447
18. D.H. Gorski, H.J. Mauceri, R.M. Salloum, S. Gately, S. Hellman, and M.A. Beckett Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin Cancer Res 58 1998 5686 5689
19. S.M. Frisch, K. Vuori, E. Ruoslahti, and P.Y. Chan-Hui Control of adhesion-dependent cell survival by focal adhesion kinase J Cell Biol 134 1996 793 799
20. B.H. Gray, J.R. Haseman, and K.H. Mayo B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides Biochim Biophys Acta 1244 1995 185 190
21. A.W. Griffioen, and G. Molema Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation Pharmacol Rev 52 2000 237 268
22. A.W. Griffioen, D.W. van der Schaft, A.F. Barendsz-Janson, A. Cox, H.A. Struijker Boudier, and H.F. Hillen Anginex, a designed peptide that inhibits angiogenesis Biochem J 354 2001 233 242
23. S.K. Gupta, and J.P. Singh Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression J Cell Biol 127 1994 1121 1127
24. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
25. E. Ilyina, V. Roongta, and K.H. Mayo NMR structure of a de novo designed, peptide 33mer with two distinct, compact β-sheet folds Biochem J 36 1997 5245 5250
26. E.Y. Jones, E.D. Stuart, and N.P. Walker Structure of tumour necrosis factor Nature 338 1989 225 228
27. A.D. Luster, S.M. Greenberg, and P. Leder The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation J Exp Med 182 1995 219 223
28. H.J. Mauceri, N.N. Hanna, M.A. Beckett, D.H. Gorski, M.J. Staba, and K.A. Stellato Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 1998 287 291
29. K.H. Mayo, R.P. Dings, C. Flader, I. Nesmelova, B. Hargittai, and D.W. van der Schaft Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity J Biol Chem 278 46 2003 45746 45752 14
30. K.H. Mayo, J. Haseman, E. Ilyina, and Gray B. Designed β-Sheet-forming peptide 33mers with potent human bacterial/permeability increasing protein-like bacterial and endotoxin neutralizing activities Biochim Biophys Acta 1425 1998 81 92
31. K.H. Mayo, E. Ilyina, and H. Park A recipe for designing water-soluble, beta-sheet-forming peptides Protein Sci 5 1996 1301 1315
32. K.H. Mayo, D.W. van der Schaft, and A.W. Griffioen Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells Angiogenesis 4 2001 45 51
33. A.R. Mire-Sluis, D.R. Gaines, and R. Thorpe Implications for the assay and biological activity of interleukin-8: results of a WHO international collaborative study J Immunol Methods 200 1997 1 16
34. G. Molema, and A.W. Griffioen Rocking the foundations of solid tumor growth by attacking the tumor's blood supply Immunol Today 19 1998 392 394
35. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, and W.S. Lane Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
36. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, and M. Moses Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
37. N. Papo, and Y. Shai Host defense peptides as new weapons in cancer treatment Cell Mol Life Sci 62 2005 784 790
38. D. Paris, K. Townsend, A. Quadros, J. Humphrey, J. Sun, and S. Brem Inhibition of angiogenesis by Abeta peptides Angiogenesis 7 2004 75 85
39. J. Pilch, C.M. Franzin, L.M. Knowles, F.J. Ferrer, F.M. Marassi, and E. Ruoslahti The anti-angiogenic peptide anginex disrupts the cell membrane J Mol Biol 356 2006 876 885
40. S.E. Pike, L. Yao, K.D. Jones, B. Cherney, E. Appella, and K. Sakaguchi Vasostatin, a calreticulin fragment, inhibits angiogenesis and supresses tumor growth J Exp Med 188 1998 2349 2356
41. J.P. Priestle, H.P. Schar, and M.G. Grutter Crystallographic refinement of interleukin-1-beta at 2.0 A/resolution Proc Natl Acad Sci USA 86 1989 9667 9671
42. B. Robaye, R. Mosselmans, W. Fiers, J.E. Dumont, and P. Galand Tumor necrosis factor induces apoptosis in normal endothelial cells in vitro Am J Pathol 138 1991 447 453
43. F. Rastinejad, P.J. Polverini, and N.P. Bouck Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene Cell 56 1989 345 355
44. F. Re, A. Zanetti, M. Sironi, N. Polentarutti, L. Lanfrancone, and E. Dejana Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells J Cell Biol 127 1994 537 546
45. Y. Shai, and Z. Oren From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides Peptides 22 2001 1629 1641
46. L. Song, M.R. Hobaugh, C. Shustak, S. Cheley, H. Bayley, and J.E. Gouaux Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore Science 274 1996 1859 1866
47. S.P. Tabruyn, S. Memet, P. Ave, C. Verhaeghe, K.H. Mayo, and I. Struman NF-kappaB activation in endothelial cells is critical for the activity of angiostatic agents Mol Cancer Ther 8 2009 2645 2654
48. B.A. Teicher, E.A. Sotomayor, and Z.D. Huang Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease Cancer Res 52 1992 6702 6704
49. V.L. Thijssen, R. Postel, R.J. Brandwijk, R.P. Dings, I. Nesmelova, and S. Satijn Galectin-1 is essential in angiogenesis and is a target for anti-angiogenesis therapy Proc Natl Acad Sci USA 103 2006 15975 15980
50. D.W. van der Schaft, R.P. Dings, Q.G. de Lussanet, L.I. van Eijk, A.W. Nap, and R.G. Beets-Tan The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models FASEB J 16 2002 1991 1993
51. D.W. van der Schaft, E.A. Toebes, J.R. Haseman, K.H. Mayo, and A.W. Griffioen Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells Blood 96 2000 176 181
52. U. Wilczynska, A. Kucharska, J. Szary, and S. Szala Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer Acta Biochim Pol 48 2001 1077 1084
53. M. Yi, T. Sakai, R. Fassler, and E. Ruoslahti Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity Proc Natl Acad Sci USA 100 2003 11435 11438